Status:
COMPLETED
Performance of the Tasman Continuous Positive Airway Pressure (CPAP) System
Lead Sponsor:
ResMed
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Assessment of the performance of the Tasman CPAP system in treating obstructive sleep apnea. The purpose of this study is to (1) evaluate the performance of this system in the efficacy of the treatmen...
Detailed Description
Obstructive Sleep Apnoea (OSA) is a condition characterised by partial or complete collapse of the upper airway during sleep. The treatment of choice for OSA is Continuous Positive Airway Pressure (CP...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Patients willing to give written informed consent
- Patients who can read and comprehend English
- Patients being treated for OSA for \>6 months
- Patients using a ResMed nasal mask system
- Patients who can trial the trial mask for 7 nights
- Exclusion Criteria
- Patients not willing to give written informed consent
- Patients who can not read and comprehend English
- Patients being treated for OSA for \<6 months
- Patients using an inappropriate mask system
- Patients using Bilevel flow generators
- Patients who are not using CPAP between 7 and 13 cmH2O
- Patients who are pregnant
- Patients who cannot trial the trial mask for 7 nights
- Patients with a hearing impairment
Exclusion
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT01171066
Start Date
June 1 2010
End Date
October 1 2012
Last Update
February 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ResMed Ltd
Sydney, New South Wales, Australia, 2155